@ShahidNShah
FDA approves new medicine for aggressive pancreatic cancer, extending survival by 11.1 months in phase 3 trial.Read on beckershospitalreview.com
August 21 to August 22, 2023
Barcelona, Spain
A sizable portion of American people (49.1 percent) attempted to lose weight between 2013 and 2016, which contributed to the increase in weight reduction drugs in both popular culture and medical …
Posted Jul 5, 2023 Health and Wellness Physical Fitness Drugs
February 27 to February 28, 2023
The Westin Crystal City Reagan National Airport, 1800 Richmond Highway, Arlington, Virginia, 22202, United States
Hemgenix is approved for patients who currently use factor IX prophylaxis therapy or have serious hemorrhage or spontaneous bleeding episodes. The adeno-associated virus vector-based gene therapy …
Posted Nov 25, 2022 Biotech Drugs Chemistry, Pharmaceutical
Provention Bio's teplizumab is meant to prevent the onset of Type 1 diabetes. To be sold as Tzield, the drug will cost $193,900 for a typical full regimen. Tzield is an antibody that was initially …
Posted Nov 19, 2022 Digital Therapeutics Solutions for Diabetes Drugs
The FDA on April 28 approved Bristol Myers Squibb's Camzyos, the first drug to target the cause of obstructive hypertrophic cardiomyopathy. The disease causes the heart muscle to thicken, which …
Posted May 1, 2022 Cardiology Hemodynamics Drugs
Fake drugs take the lives of hundreds of thousands of people annualy. A new idea can give a powerfull and very accessible tool to patients to avoid risks According to the World Health Organisation …
Posted Mar 22, 2022 Drugs
The U.S. Food and Drug Administration has released a draft guidance focused on using digital health technologies to acquire data remotely from participants in clinical investigations of medical …
Posted Jan 3, 2022 Drugs
Here are four FDA drug or treatment approvals Becker's has covered since Nov. 15, starting with the most recent: Here are four FDA drug or treatment approvals Becker's has covered since Nov. 15, …
Posted Dec 30, 2021 Drug Development Drugs
April 26 to April 27, 2021
It is an online event.
Varithena is FDA-approved for treating varicose veins caused by problems with the great saphenous vein (GSV) and related veins in the legs GSV system both above and below the knee. Unique CPT codes …
Published Jan 1, 2022 Disease Prevention Life Sciences Tools Drugs Medication Management
Last Updated
Voraxaze® is a carboxypeptidase indicated to reduce toxic plasma methotrexate concentration in adult and pediatric patients with delayed methotrexate clearance due to impaired renal function. …
Published Jan 1, 2022 Medication Management Drugs
Last Updated
DigiFab® Digoxin Immune Fab is a sterile, purified, lyophilized preparation of digoxin-immune ovine Fab immunoglobulin fragments. The product contains no preservatives and is intended for intravenous …
Published Jan 1, 2022 Drugs
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 20, 2024 at 12:59pm